Drug Design, Cancer & Toxicity Research Theme
Research in Drug Design encompasses the entire spectrum from Bench to Bedside, with the aim of enabling the delivery of novel, safe, therapeutics to patients, leading to an increase in Health and Well-being within the general population. Our multi-disciplinary approach draws together World-leading researchers from across the University of Surrey, coupled with strong collaborations with academic partners and the Pharmaceutical sector. Such partnerships allow us to develop novel approaches to the design and isolation of novel therapeutic agents, their testing within in silico and in vitro models, and ultimately the translation of such research into clinical practice.
So what is Drug Design? And what the hot topics in the field today? To find out the latest news in the area of Drug Design, Cancer and Toxicity, as well as introductions to the major areas within the theme, please visit our podcast page.
• The development of novel therapeutic agents derived from natural plant products
• The use of '-omic' level measurements, coupled with in silico modelling, to develop systems-level understanding of cellular response to chemical challenge
• Nuclear Receptor Biology and their role in coordinating cellular response to chemical challenge. Special focus on the diseases of aging, including cardiovascular, metabolic and oncology
• The molecular mechanisms of DNA damage repair, with particular emphasis on their role in human degenerative diseases
• Breast, ovarian and prostate cancer research, developing both novel therapeutics and understanding the development of multiple-drug resistance phenotype within these diseases. Cancer Research theme page.
To find out more about the research activities of the DDCT theme click here.
Find out more about the research going on within the DDCT theme at Surrey by looking at our Publication Highlights.